N-6022

N/A

Report date: 2024/10/16 17:38:14
NME

Base Information

Drug NameN-6022
Drug Alias NameN-6022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutathione-independent formaldehyde dehydrogenase inhibitorsAlcohol dehydrogenases inhibitorsNitric oxide stimulants
TargetsGlutathione-independent formaldehyde dehydrogenaseAlcohol dehydrogenases
Therapy Area/IndicationsAsthmaCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNivalis Therapeutics, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNivalis Therapeutics, Inc
Active IndicationsN/A
Inactive IndicationsAsthmaCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A